Great Lakes Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $506K | Buy |
|
|||||
|
2025
Q2 | $443K | Sell |
|
|||||
|
2025
Q1 | $3.54M | Buy |
|
|||||
|
2024
Q4 | $624K | Sell |
|
|||||
|
2024
Q3 | $1.2M | Sell |
|
|||||
|
2024
Q2 | $15.3M | Sell |
|
|||||
|
2024
Q1 | $15.9M | Sell |
|
|||||
|
2023
Q4 | $21.5M | Buy |
|
|||||
|
2023
Q3 | $18.2M | Buy |
|
|||||
|
2023
Q2 | $3.81M | Sell |
|
|||||
|
2023
Q1 | $8.47M | Buy |
|
|||||
|
2022
Q4 | $5.04M | Sell |
|
|||||
|
2022
Q3 | $4.58M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $9.27M | Buy |
|